Seminars in Oncology
Volume 31, Issue 4 , Pages 542-553 , August 2004

Surgery for upper gastrointestinal malignancies

  • J.J. Bonenkamp

      Affiliations

    • Department of Surgery, University Medical Center, Nijmegen, The Netherlands
    • Corresponding Author InformationAddress reprint requests to J.J. Bonenkamp MD, PhD, Department of Surgery, University Medical Center St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands

References 

  1. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053
  2. Dolan K, Morris AI, Gosney JR, et al.  Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?. J Gastroenterol Hepatol. 2004;19:24–30
  3. World Health Organisation . The World Health Report. Geneva, Switzerland: WHO; 1997;
  4. Allum WH, Powell DJ, McConckey CC, et al.  Gastric cancer (A 25 year review). Br J Surg. 1989;76:535–540
  5. Coller FA, Kay EB, McIntyre RS. Regional lymphatic metastases of carcinoma of the stomach. Arch Surg. 1942;43:748–761
  6. Gilbertsen VA. Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a report of 1983 cases. Cancer. 1969;23:1305–1308
  7. McNeer G, Lawrence W, Ortega LG, et al.  Early results of extended total gastrectomy for cancer. Cancer. 1956;9:1153–1159
  8. Kajitani T. Japanese Research Society for the Study of Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg. 1981;11:127–145
  9. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75:110–112
  10. Robertson CS, Chung SCS, Woods SDS, et al.  A prospective randomised trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994;220:176–182
  11. Bonenkamp JJ, Hermans J, van de Velde CJH, et al.  Evaluation of extended lymph node dissection in the randomised D1-D2 Dutch Gastric Cancer Trial. N Engl J Med. 1999;340:908–914
  12. Cuschieri A, Weeden S, Fielding J, et al.  Patient survival after D1 and D2 resections for gastric cancer (Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group). Br J Cancer. 1999;79:1522–1530
  13. McCulloch P, Nita ME, Kazi H, et al.  Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach (Cochrane Review). The Cochrane Library. Chichester, UK: Wiley; 2003; Issue 4
  14. McCulloch P. Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980–1985. Br J Surg. 1994;81:417–420
  15. Callahan MA, Christos PJ, Gold HT, et al.  Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg. 2002;238:629–639
  16. Theuer CP, Kurosaki T, Ziogas A, et al.  Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer. 2000;89:1883–1892
  17. Sasako M, Songun I, Hermans J, et al.  Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg. 1997;84: 1576–1571
  18. Kitimura K, Nishida S, Iichikawa D, et al.  No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg. 1999;86:119–122
  19. Bozetti F, Marubini E, Bonfanti G, et al.  Subtotal vs total gastrectomy for gastric cancer (Five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group). Ann Surg. 1999;230:170–178
  20. Songun I, Bonenkamp JJ, Hermans J, et al.  Prognostic value of resection line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer. 1996;32:433–437
  21. Katai H, Sano T, Fukagawa T, et al.  Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg. 2003;90:850–853
  22. Chareton B, Landen S, Manganas D, et al.  Prospective randomized trial comparing Billroth I and Billroth II procedures for carcinoma of the gastric antrum. J Am Coll Surg. 1996;183:190–194
  23. Monson JR, Donohue JH, McIlrath DC, et al.  Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer. 1991;68:1863–1868
  24. Hartgrink HH, Putter H, Klein Kranenbarg E, et al.  Value of palliative resection in gastric cancer. Br J Surg. 2002;89:1438–1443
  25. Guadagni S, Reed PI, Johnston BJ, et al.  Early gastric cancer (Follow-up after gastrectomy in 159 patients). Br J Surg. 1993;80:325–328
  26. Yamazaki H, Oshima A, Murakami R, et al.  A long-term follow-up study of patients with gastric cancer detected by mass screening. Cancer. 1989;63:613–617
  27. Bonenkamp JJ, Van de Velde CJH, Kampschöer GHM, et al.  Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J Surg. 1993;17:410–415
  28. Hampson L, Shennib H, Lough J, et al.  Early gastric cancer (is it a distinct clinical entity?). Can Assoc Gen Surg. 1990;33:349–352
  29. Tsukuma H, Mishima T, Oshima A. Prospective study of “early” gastric cancer. J Cancer. 1983;31:421–426
  30. Yoshikawa T, Tsuburaya A, Kobayashi O, et al.  Is D2 lymph node dissection necessary for early gastric cancer?. Ann Surg Oncol. 2002;9:401–405
  31. Ohyama T, Kobayashi Y, Mori K, et al.  Factors affecting complete resection of gastric tumors by the endoscopic mucosal resection procedure. J Gastroenterol Hepatol. 2002;17:844–848
  32. Lerut T, Coosemans W, Decker G, et al.  Cancer of the esophagus and gastroesophageal junction (Potentially curative therapies). Surg Oncol. 2001;10:113–122
  33. Ponsioen CY, Welvaart K, Hermans J. Significance of tumour invasion and lymph node involvement on the prognosis and selection for surgery of adenocarcinoma of the cardia. Eur J Surg. 1989;15:301–306
  34. Steup WH, De Leyn P, Deneffe G, et al.  Tumors of the esophagogastric junction. Long term survival in relation to patterns of lymph node metastases and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111:85–95
  35. Wobst A, Audisio RA, Colleoni M, et al.  Oesophageal cancer treatment (Studies, strategies and facts). Ann Oncol. 1998;9:951–962
  36. Lewis I. The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growths of the middle third. Br J Surg. 1946;34:18–31
  37. Orringer MB, Sloan H. Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg. 1978;76:643–648
  38. Akiyama H, Tsurumaru M, Watanabe G, et al.  Development of surgery for carcinoma of the esophagus. Am J Surg. 1984;147:9–13
  39. Hulscher JB, Tijssen JG, Obertop H, et al.  Transthoracic versus transhiatal resexction for carcinoma of the esophagus (A meta-analysis). Ann Thorac Surg. 2001;72:306–313
  40. Hulscher JB, Sandick JW, van de Boer AG, et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–1669
  41. Manshanden CG, Hulscher JB, Hovius M, et al.  Limited resection for carcinoma of the upper thoracic esophagus is not a realistic option. Eur J Surg Oncol. 2000;26:561–566
  42. Kitagawa Y, Kitajima M. Gastrointestinal cancer and sentinel node navigation surgery. J Surg Oncol. 2002;79:188–193
  43. Harisinghani MG, Barentsz J, Hahn PF, et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491–2499
  44. Wallace MB, Nietert PJ, Earle C, et al.  An analysis of multiple staging management strategies for carcinoma of the esophagus (Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy). Ann Thorac Surg. 2002;74:1026–1032
  45. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al.  Minimally invasive esophagectomy. Outcomes in 222 patients. Ann Surg. 2003;238:486–495

PII: S0093-7754(04)00233-7

doi: 10.1053/j.seminoncol.2004.04.012

Seminars in Oncology
Volume 31, Issue 4 , Pages 542-553 , August 2004